GE HealthCare Technologies (NASDAQ:GEHC) Director Kevin Lobo Purchases 10,000 Shares of Stock

GE HealthCare Technologies Inc. (NASDAQ:GEHC) Director Kevin Lobo purchased 10,000 shares of the firm’s stock in a transaction that occurred on Friday, May 22nd. The stock was acquired at an average price of $64.18 per share, with a total value of $641,800.00. Following the completion of the purchase, the director owned 14,363 shares in the company, valued at $921,817.34. This represents a 229.20% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

GE HealthCare Technologies Stock Down 0.1%

Shares of GE HealthCare Technologies stock opened at $64.18 on Wednesday. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95. The company has a 50-day moving average of $68.20 and a 200 day moving average of $76.10. The firm has a market cap of $29.19 billion, a price-to-earnings ratio of 15.35, a PEG ratio of 1.45 and a beta of 0.74. GE HealthCare Technologies Inc. has a 1 year low of $58.75 and a 1 year high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. During the same quarter in the previous year, the business earned $1.01 earnings per share. The firm’s revenue was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several analysts recently commented on GEHC shares. Wells Fargo & Company cut their price objective on shares of GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating on the stock in a research report on Thursday, April 30th. BTIG Research cut their price objective on shares of GE HealthCare Technologies from $85.00 to $80.00 and set a “buy” rating on the stock in a research report on Wednesday, April 29th. Rothschild & Co Redburn cut their price objective on shares of GE HealthCare Technologies from $110.00 to $98.00 in a research report on Thursday, April 30th. Mizuho cut their price objective on shares of GE HealthCare Technologies from $90.00 to $80.00 in a research report on Thursday, April 30th. Finally, JPMorgan Chase & Co. cut their price objective on shares of GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a research report on Thursday, April 30th. Nine research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and a consensus price target of $80.21.

Institutional Trading of GE HealthCare Technologies

A number of institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. boosted its holdings in shares of GE HealthCare Technologies by 0.5% during the 4th quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock valued at $4,287,658,000 after acquiring an additional 267,058 shares during the last quarter. Auto Owners Insurance Co boosted its holdings in shares of GE HealthCare Technologies by 9,525.4% during the 4th quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock valued at $278,725,000 after acquiring an additional 33,629,559 shares during the last quarter. Dodge & Cox boosted its holdings in shares of GE HealthCare Technologies by 13.4% during the 4th quarter. Dodge & Cox now owns 31,211,229 shares of the company’s stock valued at $2,559,945,000 after acquiring an additional 3,693,918 shares during the last quarter. Capital Research Global Investors boosted its holdings in shares of GE HealthCare Technologies by 1.6% during the 4th quarter. Capital Research Global Investors now owns 25,362,352 shares of the company’s stock valued at $2,080,248,000 after acquiring an additional 389,796 shares during the last quarter. Finally, State Street Corp boosted its holdings in shares of GE HealthCare Technologies by 2.0% during the 4th quarter. State Street Corp now owns 20,049,677 shares of the company’s stock valued at $1,644,475,000 after acquiring an additional 401,932 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.